PIRAMAL PHARMA
Back to All Ratios
|
PIRAMAL PHARMA Last 5 Year EV/CE History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
EV/CE(x) | 1.69 | 1.09 | 0.46 | 0.33 |
What is the latest EV/CE ratio of PIRAMAL PHARMA ?
Year | EV/CE |
---|---|
Mar2024 | 1.69 |
Mar2023 | 1.09 |
Mar2022 | 0.46 |
Mar2021 | 0.33 |
How is EV/CE of PIRAMAL PHARMA Trending?
Years | EV/CE | % Change | |
---|---|---|---|
Mar2024 | 1.69 | 55.05 | |
Mar2023 | 1.09 | 136.96 | |
Mar2022 | 0.46 | 39.39 | |
Mar2021 | 0.33 | - |
Other Financial Ratios of PIRAMAL PHARMA
Operational & Financial Ratios Earnings Per Share CEPS DPS Book NAV/Share Tax Rate | Margin Ratios Core EBITDA Margin EBIT Margin Pre Tax Margin PAT Margin Cash Profit Margin | Performance Ratios ROA ROE ROCE Asset Turnover Sales/Fixed Asset Working Capital/Sales | Efficiency Ratios Fixed Capital/Sales Receivable days Inventory Days Payable days | Valuation Parameters PER PCE Price/Book Yield EV/Net Sales EV/Core EBITDA EV/EBIT M Cap / Sales | Growth Ratios Net Sales Growth Core EBITDA Growth EBIT Growth PAT Growth EPS Growth | Financial Stability Ratios Total Debt/Equity Current Ratio Quick Ratio Interest Cover Total Debt/Mcap |
Compare EV/CE ratio of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹27,434.7 Cr | 0.4% | 0.2% | 39.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹403,076.0 Cr | 0.3% | -4.9% | 15.8% | Stock Analytics | |
DIVIS LABORATORIES | ₹173,924.0 Cr | 0.2% | 10% | 53.5% | Stock Analytics | |
CIPLA | ₹121,456.0 Cr | 2.3% | 1.1% | 2.6% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,197.0 Cr | 5.7% | 15% | 11.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,761.0 Cr | 0.8% | -0.9% | 17.4% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | 0.4% |
0.2% |
39.4% |
SENSEX | 0.9% |
1.8% |
11.1% |
You may also like the below Video Courses